title: Repeated treatment with quinolones potentiates the seizures induced by aminophylline in genetically epilepsy-prone rats.
abstract: 1. The effects of a chronic treatment with several quinolone derivatives on on the aminophylline-induced convulsions in the genetically epilepsy-prone rat have been investigated. 2. Two series of experiments have been performed: in the first one animals received the quinolone twice a day for 5 days, then were given aminophylline (80-140 mg.kg-1, i.p.); in the second series of experiments the rats were treated once a day with the quinolone plus 120 mg.kg-1 of aminophylline for 5 days. The changes induced by both treatment protocols on electrocortical activity and on the occurrance of seizures have been evaluated. 3. Enoxacin reduced the dose of aminophylline necessary for the induction of seizures in a higher degree with respect to the other quinolone derivatives. The derivatives which showed minor proconvulsant properties were ofloxacin, ciprofloxacin and cinoxacin. The potentiation of seizures induced by quinolones appeared a dose-dependent phenomenon which was more evident when high doses of quinolones were used. 4. The chronic treatment carried out daily with quinolones and aminophylline suggests that additive neurotoxic effects of both classes of drugs may contribute to the increase of severity of seizure scores. 5. The possible role of GABA-benzodiazepine, excitatory amino acid, purinergic mechanisms as well as the role of pharmacokynetic factors are discussed.
authors.affiliation: Institute of Pharmacology, School of Medicine, University of Messina, Italy.
authors.forename: A
authors.initials: A
authors.lastname: De Sarro
authors.forename: G R
authors.initials: GR
authors.lastname: Trimarchi
authors.forename: D
authors.initials: D
authors.lastname: Ammendola
authors.forename: G
authors.initials: G
authors.lastname: De Sarro
mesh_terms: D000628:Aminophylline / Q000627:therapeutic use*; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects; D004195:Disease Models, Animal; D004357:Drug Synergism; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D011810:Quinoxalines / Q000627:therapeutic use*; D051381:Rats; D011922:Rats, Mutant Strains; D017207:Rats, Sprague-Dawley; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology
chemical_list: D011810:Quinoxalines; D000628:Aminophylline